参考文献

[1]Rowley AH, Baker SC, Shulman ST, et al.Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki disease [J].J Infect Dis,2005,192(10):1757-1766.

[2]Rowley AH, Baker SC, Shulman ST, et al.Ultrastructural, immuno-fluorescence, and RNA evidence support the hypothesis of a“new”virus associated with Kawasaki disease [J].J Infect Dis,2011,203(7):1021-1030.

[3]Rowley AH, Baker SC, Shulman ST, et al.RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease [J].PLoS ONE,2008,3(2):e1582.

[4]Chang LY, Lu CY, Shao PL, et al.Viral infections associated with Kawasaki disease [J].J Formos Med Assoc,2014,113(3):148-154.

[5]Jaggi P, Kajon AE, Mejias A, et al.Human adenovirus infection in Kawasaki disease:a confounding bystander [J].Clin Infect Dis,2013, 56(1):58-64.

[6]Shike H, Shimizu C, Kanegaye JT, et al.Adenovirus, adeno-associated virus and Kawasaki disease [J].Pediatr Infect Dis J,2005, 24(11):1011-1014.

[7]Shimizu C, Shike H, Baker SC, et al.Human coronavirus NL63 is not detected in the respiratory tracts of children with acute Kawasaki disease [J].J Infect Dis,2005,192(10):1767-1771.

[8]Esper F, Shapiro ED, Weibel C, et al.Association between a novel human coronavirus and Kawasaki disease [J].J Infect Dis,2005,191 (4):499-502.

[9]Dominguez SR, Anderson MS, Glode MP, et al.Blinded casecontrol study of the relationship between human coronavirus NL63 and Kawasaki syndrome [J].J Infect Dis,2006,194(12):1697-1701.

[10]Chang LY, Chiang BL, Kao CL, et al.Lack of association between infection with a novel human coronavirus(HCoV), HCoV-NH, and Kawasaki disease in Taiwan[J].J Infect Dis,2006,193(2):283-286.

[11]Shirato K, Imada Y, Kawase M, et al.Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease [J].J Med Virol,2014,86(12):2146-2153.

[12]Catalano-Pons C, Giraud C, Rozenberg F, et al.Detection of human bocavirus in children with Kawasaki disease [J].Clin Microbiol Infect,2007,13(12):1220-1222.

[13]Bajolle F, Meritet JF, Rozenberg F, et al.Markers of a recent bocavirus infection in children with Kawasaki disease: a year prospective study [J].Pathol Biol(Paris),2014,62(6):365-368.

[14]Hua W, Izurieta HS, Slade B, et al.Kawasaki disease after vaccination:reports to the vaccine adverse event reporting system 1990-2007 [J].Pediatr Infect Dis J,2009,28(11):943-947.

[15]MacNeil A, Holman RC, Yorita KL, et al.Evaluation of seasonal patterns of Kawasaki syndrome-and rotavirus-associated hospitalizations in California and New York,2000-2005 [J].BMC Pediatr, 2009,9:65.

[16]Lee SJ, Lee KY, Han JW, et al.Epstein-Barr virus antibodies in Kawasaki disease [J].Yonsei Med J,2006,47(4):475-479.

[17]Takeshita S, Kobayashi I, Kawamura Y, et al.Characteristic profile of intestinal microflora in Kawasaki disease [J].Acta Paediatr,2002, 91(7):783-788.

[18]Nagata S, Yamashiro Y, Ohtsuka Y, et al.Heat shock proteins and superantigenic properties of bacteria from the gastrointestinal tract of patients with Kawasaki disease [J].Immunology,2009,128(4):511-520.

[19]Horita N, Yokota S, Fuse S, et al.The throat flora and its mitogenic activity in patients with Kawasaki disease [J].Microbiol Immunol, 2004,48(11):899-903.

[20]Tseng HF, Sy LS, Liu IL, et al.Postlicensure surveillance for prespecified adverse events following the 13-valent pneumococcal conjugate vaccine in children [J].Vaccine,2013,31(22):2578-2583.

[21]Vincent P, Salo E, Skurnik M, et al.Similarities of Kawasaki disease and Yersinia pseudotuberculosis infection epidemiology [J].Pediatr Infect Dis J,2007,26(7):629-631.

[22]Tahara M, Baba K, Waki K, et al.Analysis of Kawasaki disease showing elevated antibody titres of Yersinia pseudotuberculosis [J].Acta Paediatr,2006,95(12):1661-1664.

[23]Chou CT, Chang JS, Ooi SE, et al.Serum anti Yersinia antibody in Chinese patients with Kawasaki disease [J].Arch Med Res,2005,36 (1):14-18.

[24]Kusuda T, Nakashima Y, Murata K, et al.Kawasaki diseasespecific molecules in the sera are linked to microbe-associated molecular patterns in the biofilms [J].PLoS ONE,2014,9(11):e113054.

[25]Hammerschlag MR, Boman J, Rowley AH.Failure to demonstrate Chlamydia pneumoniae in cardiovascular tissue from children with Kawasaki disease [J].Pediatr Infect Dis J,2001,20(1):76-77.

[26]Strigl S, Kutlin A, Roblin PM, et al.Is there an association between Kawasaki disease and Chlamydia pneumoniae [J].J Infect Dis,2000, 181(6):2103-2105.

[27]Schrag SJ, Besser RE, Olson C, et al.Lack of association between Kawasaki syndrome and Chlamydia pneumoniae infection:an investigation of a Kawasaki syndrome cluster in San Diego County [J]. Pediatr Infect Dis J,2000,19(1):17-22.

[28]Kafetzis DA, Maltezou HC, Constantopoulou I, et al.Lack of association between Kawasaki syndrome and infection with Rickettsia conorii, Rickettsia typhi, Coxiella burnetii or Ehrlichia phagocytophila group [J].Pediatr Infect Dis J,2001,20(7):703-706.

[29]Sopontammarak S, Promphan W, Roymanee S, Phetpisan S.Positive serology for dengue viral infection in pediatric patients with Kawasaki disease in southern Thailand [J].Circ J,2008,72(9):1492-1494.

[30]Jordan-Villegas A, Chang ML, Ramilo O, et al. Concomitant respiratory viral infections in children with Kawasaki disease [J]. Pediatr Infect Dis J,2010,29(8):770-772.

[31]Benseler SM, McCrindle BW, Silverman ED, et al.Infections and Kawasaki disease:implications for coronary artery outcome [J]. Pediatrics,2005,116(6):e760-e766.